TX-based Modicus Prime, AI software automating image analysis to accelerate process development and reduce commercial production costs has raised $3.5 Million Seed Funding led by Silverton Partners with additional backing from Alumni Ventures and other leading venture firms.
Read also – [Funding News] Digestiva Secures $18.4 Million Series A Funding
The funding follows the implementation of AI quality control software, mpVision, across multiple global pharmaceutical companies, CMOs, and CDMOs manufacturing biologics, cell and gene therapies, and vaccines.
Read also – Funding Wrap of the Week | American Startups Funding Roundup | July 8 – July 12
A former engineer and data scientist from Shire and Bayer Pharmaceuticals, Chartier states, “When the Modicus Prime team meets with scientists and automation teams at pharma companies, we usually hear about long assay and software turnaround times limiting their ability to take immediate action during commercial production. In response, pharmaceutical domain experts guided the construction of mpVision’s cloud ecosystem to be their natural quality control solution.”
As part of the financing round, Silverton Partners’ Roger Chen joins the Company’s board of directors.
Silverton Partner Roger Chen states, “This company is responding to the pharmaceutical industry’s current demands, delivering a welcomed cloud technology that’s already yielding practical results. We are very enthusiastic about supporting this movement.”
About Modicus Prime
Founded in 2020, Modicus Prime’s Self-Service software places cutting-edge AI where it belongs: in the hands of biotechnology experts. Our computer vision solution, mpVision, provides intelligent image analysis to monitor biologics at any scale.
mpVision has been tested by scientists in a Top 10 Pharma company supporting our mission to eliminate contamination from the pharmaceutical industry. These contaminations cost 100’s of millions of dollars per incident as illustrated by the recent Covid vaccine 60 M incident experienced by J&J/AstraZeneca/Emergent. Such unmet needs of the Life Sciences industry, including real-time product quality assurance, full agency compliance, faster go-to-market, and reduced operating costs, are being met with Modicus Prime’s Self-Service AI solution.
